Inogen Stock
Inogen, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Kevin R. Smith
- Employees
- 753
- Market cap
- $166 M
- IPO
- 14/02/2014
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range…
Inogen stock: price history
1D
-0.8%
1W
+1.1%
1M
+21.8%
6M
-8.4%
YTD
-7.0%
1Y
-26.6%
2Y
-33.4%
5Y
-84.7%
10Y
-88.9%
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~117% stronger price swings than usual
Ask the agents about Inogen
Analyst assessment of Inogen
PRICE TARGET LOW
US$26.00
CONSENSUS
US$26.00
MEDIAN
US$26.00
PRICE TARGET HIGH
US$26.00
0
STRONG BUY
6
BUY
4
HOLD
1
SELL
0
STRONG SELL
11
TOTAL · Buy
As of: 22/05/2025
Inogen stock metrics
P/E
-6.94
P/B
0.97
EV/EBITDA
-17.32
RETURN ON EQUITY
-2.2%
NET MARGIN
-4.0%
DEBT/EQUITY
0.09
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
87.1%
FLOAT SHARES
23,126,834
AVG. DAILY VOLUME (30D)
360,355
Insider transactions (SEC)
Smith Kevin Raymond Merrill
Wright Mary E
Smith Kevin P.
Smith Kevin P.
Smith Kevin P.
Institutional holders
Comparable stocks
Frequently asked questions about Inogen stock
What does Inogen do?
Inogen, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Kevin R. Smith, the company employs around 753 people.
The IPO was on 14/02/2014; the stock trades on NASDAQ under the ticker INGN.
What do analysts say about Inogen stock?
11 analysts rate the stock, the consensus is Buy (as of 22/05/2025).
The average price target is US$26.00, ranging from US$26.00 to US$26.00, with a median of US$26.00.
This is an external assessment, not a statement by Market Jury.
When does Inogen report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 117% stronger than usual.
Does Inogen pay a dividend?
No, Inogen currently does not pay a dividend.
Which stocks are comparable to Inogen?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Inogen stock analyzed?
Clicking "Analyze stock" lets five strategies assess Inogen against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.